State Street Corp Cabaletta Bio, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, State Street Corp holds 896,123 shares of CABA stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

896,123

Previous 2,005,801 55.32%

Holding current value

$2.05 Million

Previous $15 Million 71.81%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.94 - $8.24 $4.37 Million - $9.14 Million	-1,109,678 Reduced 55.32%	896,123 $4.23 Million
Q2 2024 Aug 14, 2024	SELL	$7.22 - $18.82 $12.5 Million - $32.7 Million	-1,735,659 Reduced 46.39%	2,005,801 $15 Million
Q1 2024 May 15, 2024	BUY	$16.79 - $25.38 $19.3 Million - $29.1 Million	1,146,990 Added 44.21%	3,741,460 $63.8 Million
Q4 2023 Feb 14, 2024	BUY	$12.21 - $23.36 $13 Million - $24.8 Million	1,061,628 Added 69.26%	2,594,470 $58.9 Million
Q3 2023 Nov 14, 2023	BUY	$11.84 - $18.65 $12.7 Million - $20 Million	1,071,345 Added 232.15%	1,532,842 $23.3 Million
Q2 2023 Aug 14, 2023	BUY	$7.65 - $13.95 $2.9 Million - $5.29 Million	379,030 Added 459.61%	461,497 $5.96 Million
Q1 2023 May 15, 2023	SELL	$7.08 - $12.62 $36,816 - $65,624	-5,200 Reduced 5.93%	82,467 $682,000
Q4 2022 Feb 14, 2023	BUY	$0.64 - $9.3 $17,152 - $249,240	26,800 Added 44.03%	87,667 $810,000
Q2 2022 Aug 15, 2022	BUY	$0.99 - $2.11 $2,079 - $4,431	2,100 Added 3.57%	60,867 $65,000
Q1 2022 May 16, 2022	BUY	$1.68 - $3.92 $4,636 - $10,819	2,760 Added 4.93%	58,767 $119,000
Q4 2021 Feb 14, 2022	BUY	$3.36 - $14.64 $47,040 - $204,960	14,000 Added 33.33%	56,007 $212,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $12.5 $134,400 - $240,000	19,200 Added 84.18%	42,007 $511,000
Q2 2021 Aug 16, 2021	SELL	$7.2 - $11.73 $1.31 Million - $2.13 Million	-181,509 Reduced 88.84%	22,807 $196,000
Q1 2021 May 17, 2021	BUY	$10.39 - $14.53 $48,677 - $68,073	4,685 Added 2.35%	204,316 $2.27 Million
Q4 2020 Feb 16, 2021	BUY	$9.81 - $15.8 $362,155 - $583,288	36,917 Added 22.69%	199,631 $2.49 Million
Q3 2020 Nov 10, 2020	BUY	$9.71 - $14.41 $283,745 - $421,089	29,222 Added 21.89%	162,714 $1.76 Million
Q2 2020 Aug 14, 2020	BUY	$6.39 - $11.28 $179,514 - $316,889	28,093 Added 26.65%	133,492 $1.49 Million
Q1 2020 May 11, 2020	BUY	$6.0 - $18.67 $632,394 - $1.97 Million	105,399 New	105,399 $769,000

Others Institutions Holding CABA

# of Institutions

126

Shares Held

47.9M

Call Options Held

202K

Put Options Held

110K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Cabaletta Bio, Inc. Transaction History